PROK2 and Alzheimer disease: Here, we demonstrated that PROK2 mRNA was significantly upregulated in both the prefrontal cortex and the hippocampus of Aβ1-42 injected rats, a widely used AD non-transgenic animal model, remaining at the same level up to 35 days after the infusion.